LENALIDOMIDE
Generic: LENALIDOMIDE
Apotex Corp.Manufacturer
ORALRoute
LENALIDOMIDEActive Substance
2022-08-30Original Approval
LENALIDOMIDE is FDA application ANDA211022, sponsored by APOTEX. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
OFF LABEL USE
6,692 reports
2
DIARRHOEA
4,627 reports
3
FATIGUE
3,645 reports
4
PLASMA CELL MYELOMA
3,584 reports
5
PNEUMONIA
3,491 reports
6
DEATH
3,284 reports
7
NEUTROPENIA
2,887 reports
8
PRODUCT DOSE OMISSION ISSUE
2,793 reports
9
RASH
2,773 reports
10
THERAPY INTERRUPTED
2,271 reports